Provided by Tiger Trade Technology Pte. Ltd.

Warren Buffett holdings

3,248.53
+12.710.39%
Number of Gainers:31
Number of Losers:4
Number of Flat:- -
PE:- -
High:3,257.53
Open:3,234.79
Low:3,230.74
Close:3,235.82
Volume:360.94M
Turnover:44.73B
Market Cap:11.56T
Float Cap:10.98T

Loading ...

SoFi Tech Solutions, Orbi and Mastercard Partner to Launch Crypto-Linked Card in Mexico

THOMSON REUTERS
·
Yesterday

【US Pre-Market】Oil Surges Over 4%, Three Major Stock Index Futures Fall as Broadcom's $50 Billion AI Chip Financing and Micron Strike Draw Focus

TradingKey
·
Yesterday

Breakingviews-Elon Musk Readies His Signature Gambit at SpaceX

Reuters
·
Yesterday

Fed Minutes Strike Hawkish Tone, Strong Dollar and Treasury Yields Keep Pressuring Gold

Deep News
·
Yesterday

Universal Display Falls After Citi Cuts Rating

Reuters
·
Yesterday

Bristol-Myers Squibb (BMY) Receives a Buy from J.P. Morgan

TIPRANKS
·
Yesterday

Evercore ISI Adjusts Price Target on Chubb to $383 From $374

MT Newswires Live
·
Yesterday

U.S. Stocks on the MOVE-Royal Caribbean, Generac

Reuters
·
Yesterday

Merck & Company (MRK) Receives a Buy from BMO Capital

TIPRANKS
·
Yesterday

These Analysts Slash Their Forecasts On Constellation Brands Following Q2 Results

Benzinga Earnings
·
Yesterday

Cannabis Firm Tilray's Q1 Revenue Rises 82% on BrewDog Acquisition

Reuters
·
Yesterday

Bristol Myers’ zenbexus in combination shows efficacy in Phase 3 myeloma trial

TIPRANKS
·
Yesterday

Westinghouse Air Brake Technologies (WAB) Receives a Hold from Wells Fargo

TIPRANKS
·
Yesterday

Mexican Auto Exports Slump in September as US Tariffs Take Toll

Reuters
·
Yesterday

Bristol Myers Squibb Announces Zenbexustm (Iberdomide) in Combination with Daratumumab and Dexamethasone (Zdd) Demonstrates Superior Progression-Free Survival VS. Standard of Care in Relapsed and Refractory Multiple Myeloma in Phase 3...

THOMSON REUTERS
·
Yesterday

Bristol-Myers Squibb Company - Zdd Median Pfs 42 Months vs 20 Months for Dvd; 51% Risk Reduction

THOMSON REUTERS
·
Yesterday

Bristol-Myers Squibb Company - Serious Adverse Reactions in 58.3% and Fatal in 4.9% of Zenbexus Patients

THOMSON REUTERS
·
Yesterday

Consumer Products Maker Helen of Troy Q2 Revenue Slightly Misses; FY27 Outlook Narrowed

Reuters
·
Yesterday

Visa (V) Gets a Buy from Citi

TIPRANKS
·
Yesterday

Amazon job cuts hit hundreds as tech giant denies AI link

cityam
·
Yesterday